These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1491 related articles for article (PubMed ID: 25773268)

  • 21. Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.
    Hiatt WR; Fowkes FG; Heizer G; Berger JS; Baumgartner I; Held P; Katona BG; Mahaffey KW; Norgren L; Jones WS; Blomster J; Millegård M; Reist C; Patel MR;
    N Engl J Med; 2017 Jan; 376(1):32-40. PubMed ID: 27959717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease.
    Bansilal S; Bonaca MP; Cornel JH; Storey RF; Bhatt DL; Steg PG; Im K; Murphy SA; Angiolillo DJ; Kiss RG; Parkhomenko AN; Lopez-Sendon J; Isaza D; Goudev A; Kontny F; Held P; Jensen EC; Braunwald E; Sabatine MS; Oude Ophuis AJ
    J Am Coll Cardiol; 2018 Feb; 71(5):489-496. PubMed ID: 29406853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ticagrelor with or without Aspirin in High-Risk Patients after PCI.
    Mehran R; Baber U; Sharma SK; Cohen DJ; Angiolillo DJ; Briguori C; Cha JY; Collier T; Dangas G; Dudek D; Džavík V; Escaned J; Gil R; Gurbel P; Hamm CW; Henry T; Huber K; Kastrati A; Kaul U; Kornowski R; Krucoff M; Kunadian V; Marx SO; Mehta SR; Moliterno D; Ohman EM; Oldroyd K; Sardella G; Sartori S; Shlofmitz R; Steg PG; Weisz G; Witzenbichler B; Han YL; Pocock S; Gibson CM
    N Engl J Med; 2019 Nov; 381(21):2032-2042. PubMed ID: 31556978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54.
    Furtado RHM; Nicolau JC; Magnani G; Im K; Bhatt DL; Storey RF; Steg PG; Spinar J; Budaj A; Kontny F; Corbalan R; Kiss RG; Abola MT; Johanson P; Jensen EC; Braunwald E; Sabatine MS; Bonaca MP
    Eur Heart J; 2020 May; 41(17):1625-1632. PubMed ID: 31811715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ticagrelor versus clopidogrel in patients with acute coronary syndromes.
    Wallentin L; Becker RC; Budaj A; Cannon CP; Emanuelsson H; Held C; Horrow J; Husted S; James S; Katus H; Mahaffey KW; Scirica BM; Skene A; Steg PG; Storey RF; Harrington RA; ; Freij A; Thorsén M
    N Engl J Med; 2009 Sep; 361(11):1045-57. PubMed ID: 19717846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes).
    Easton JD; Aunes M; Albers GW; Amarenco P; Bokelund-Singh S; Denison H; Evans SR; Held P; Jahreskog M; Jonasson J; Minematsu K; Molina CA; Wang Y; Wong KSL; Johnston SC;
    Circulation; 2017 Sep; 136(10):907-916. PubMed ID: 28655834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [PEGASUS - Ticagrelor in secondary prevention on patients after a myocardial infarction].
    Špinar J; Špinarová L; Vítovec J
    Vnitr Lek; 2015 Jun; 61(6):511-5. PubMed ID: 26258965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54.
    Bonaca MP; Im K; Magnani G; Bansilal S; Dellborg M; Storey RF; Bhatt DL; Steg PG; Cohen M; Johanson P; Braunwald E; Sabatine MS
    Eur Heart J; 2022 Dec; 43(48):5037-5044. PubMed ID: 36367709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rivaroxaban in patients with a recent acute coronary syndrome.
    Mega JL; Braunwald E; Wiviott SD; Bassand JP; Bhatt DL; Bode C; Burton P; Cohen M; Cook-Bruns N; Fox KA; Goto S; Murphy SA; Plotnikov AN; Schneider D; Sun X; Verheugt FW; Gibson CM;
    N Engl J Med; 2012 Jan; 366(1):9-19. PubMed ID: 22077192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vorapaxar in the secondary prevention of atherothrombotic events.
    Morrow DA; Braunwald E; Bonaca MP; Ameriso SF; Dalby AJ; Fish MP; Fox KA; Lipka LJ; Liu X; Nicolau JC; Ophuis AJ; Paolasso E; Scirica BM; Spinar J; Theroux P; Wiviott SD; Strony J; Murphy SA;
    N Engl J Med; 2012 Apr; 366(15):1404-13. PubMed ID: 22443427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.
    Bhatt DL; Steg PG; Mehta SR; Leiter LA; Simon T; Fox K; Held C; Andersson M; Himmelmann A; Ridderstråle W; Chen J; Song Y; Diaz R; Goto S; James SK; Ray KK; Parkhomenko AN; Kosiborod MN; McGuire DK; Harrington RA;
    Lancet; 2019 Sep; 394(10204):1169-1180. PubMed ID: 31484629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Kohli P; Udell JA; Murphy SA; Cannon CP; Antman EM; Braunwald E; Wiviott SD
    J Am Coll Cardiol; 2014 Jan; 63(3):225-32. PubMed ID: 24140678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II study.
    Povsic TJ; Roe MT; Ohman EM; Steg PG; James S; Plotnikov A; Mundl H; Welsh R; Bode C; Gibson CM
    Am Heart J; 2016 Apr; 174():120-8. PubMed ID: 26995378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
    Cannon CP; Bhatt DL; Oldgren J; Lip GYH; Ellis SG; Kimura T; Maeng M; Merkely B; Zeymer U; Gropper S; Nordaby M; Kleine E; Harper R; Manassie J; Januzzi JL; Ten Berg JM; Steg PG; Hohnloser SH;
    N Engl J Med; 2017 Oct; 377(16):1513-1524. PubMed ID: 28844193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between gender and short-term outcome in patients with ST elevation myocardial infraction participating in the international, prospective, randomised Administration of Ticagrelor in the catheterisation Laboratory or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) trial: a prespecified analysis.
    Venetsanos D; Sederholm Lawesson S; Alfredsson J; Janzon M; Cequier A; Chettibi M; Goodman SG; Van't Hof AW; Montalescot G; Swahn E
    BMJ Open; 2017 Sep; 7(9):e015241. PubMed ID: 28939567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prehospital ticagrelor in ST-segment elevation myocardial infarction.
    Montalescot G; van 't Hof AW; Lapostolle F; Silvain J; Lassen JF; Bolognese L; Cantor WJ; Cequier A; Chettibi M; Goodman SG; Hammett CJ; Huber K; Janzon M; Merkely B; Storey RF; Zeymer U; Stibbe O; Ecollan P; Heutz WM; Swahn E; Collet JP; Willems FF; Baradat C; Licour M; Tsatsaris A; Vicaut E; Hamm CW;
    N Engl J Med; 2014 Sep; 371(11):1016-27. PubMed ID: 25175921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consistent platelet inhibition with ticagrelor 60 mg twice-daily following myocardial infarction regardless of diabetes status.
    Thomas MR; Angiolillo DJ; Bonaca MP; Ajjan RA; Judge HM; Rollini F; Franchi F; Ahsan AJ; Bhatt DL; Kuder JF; Steg PG; Cohen M; Muthusamy R; Sabatine MS; Storey RF
    Thromb Haemost; 2017 May; 117(5):940-947. PubMed ID: 28300867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics and outcomes in patients with a prior myocardial infarction treated with extended dual antiplatelet therapy with ticagrelor 60 mg: findings from ALETHEIA, a multi-country observational study.
    Bonaca MP; Lesén E; Giannitsis E; Hedberg J; Jernberg T; Lambrelli D; Duong M; Maggioni AP; Ariza-Solé A; Ten Berg J; Storey RF
    Eur Heart J Cardiovasc Pharmacother; 2023 Dec; 9(8):701-708. PubMed ID: 37653447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk definition and outcomes with the application of the PEGASUS-TIMI 54 trial inclusion criteria to a "real world" STEMI population: results from the Italian "CARDIO-STEMI SANREMO" registry.
    Sanchez F; Boasi V; Vercellino M; Tacchi C; Cannarile P; Pingelli N; Perri D; Gomez L; Cattunar S; Mascelli G
    BMC Cardiovasc Disord; 2021 Mar; 21(1):144. PubMed ID: 33736607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA.
    Johnston SC; Amarenco P; Denison H; Evans SR; Himmelmann A; James S; Knutsson M; Ladenvall P; Molina CA; Wang Y;
    N Engl J Med; 2020 Jul; 383(3):207-217. PubMed ID: 32668111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 75.